Evidence map›Paper›PMID 40062061›Full record

ArticleCureus2025

Successful Rescue Treatment for Acute Ischemic Stroke Due to Intracranial Atherosclerotic Disease Using the Neuroform Atlas Stent.

Yuta Oka, Yoshinobu Horio, Jota Tega, Koichiro Takemoto, Hiroshi Abe

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yuta OkaNeurosurgery, Fukuoka Seisyukai Hospital, Fukuoka, JPN.
Yoshinobu HorioNeurosurgery, Fukuoka Seisyukai Hospital, Fukuoka, JPN.
Jota TegaNeurosurgery, Fukuoka Seisyukai Hospital, Fukuoka, JPN.
Koichiro TakemotoNeurosurgery, Fukuoka University Hospital, Fukuoka, JPN.
Hiroshi AbeNeurosurgery, Fukuoka University Hospital, Fukuoka, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The recanalization rate of endovascular therapy for acute ischemic stroke in intracranial atherosclerotic disease (ICAD) is inferior to that of cardiogenic stroke. This case study presents the long-term outcomes of a patient who underwent implantation of the Neuroform Atlas stent for the treatment of intracranial carotid artery stenosis, despite repeated re-occlusions after percutaneous transluminal angioplasty (PTA). A 75-year-old woman was transferred to our hospital with aphasia. Diffusion-weighted imaging revealed the absence of recent infarction. Magnetic resonance angiography indicated an occlusion of the left internal carotid artery (ICA). Diagnostic cerebral angiography revealed severe stenosis of the left ICA, accompanied by a markedly delayed blood flow to the left middle cerebral artery region. Therefore, we decided to proceed with endovascular surgery. The guide catheter was advanced into the ICA which was spontaneously recanalized. The patient again exhibited symptoms of aphasia the next day. We decided to perform PTA, but restenosis was observed immediately. The Neuroform Atlas was placed within the stenosis. Following this, the ICA was confirmed to be open. At the one-year follow-up, cerebral angiography demonstrated optimal patency of the left ICA. The Neuroform Atlas demonstrated favorable angiographic patency over one year when implanted as a rescue stent in revascularization procedures for ICAD. Hence, its use for rescue purposes in acute settings may be considered a treatment option.

Indexed as

atherosclerosisendovascular surgeryneuroform atlasrescue stentingthrombectomy

Identifiers

PMID40062061
PMCPMC11888793

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.